Debug Stats | ### Total Build Time: 11 ms 31.860 KB CONCEPT_NAME gt=1 ms Completed: 1 ms rowSize= 334 bytesCONCEPT_SOLR_HIT_STATS gt=0 Completed: 0 ms rowSize= 14 bytesCONCEPT_DEFINITION gt=0 Completed: 0 ms rowSize= 373 bytes- Skipping details on:
CONCEPT_SYNONYM gt=NONE 0 Completed: 0 ms rowSize= 0 bytes - Skipping details on:
CONCEPT_TEXT gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_SEMANTIC_TYPE gt=0 Completed: 0 ms rowSize= 14 bytes- Skipping details on:
CONCEPT_NAMESPACE gt=NONE 0 Completed: 0 ms rowSize= 0 bytes CONCEPT_PARENTS gt=0 Completed: 0 ms rowSize= 7 bytesCONCEPT_CHILDREN gt=0 Completed: 0 ms rowSize= 8 bytesCONCEPT_ANCESTRAL_ROOTS gt=0 Completed: 0 ms rowSize= 15 bytesCONCEPT_RELATIONSHIPS gt=2 ms Completed: 2 ms rowSize= 8.107 KBCONCEPT_GENES gt=6 ms Completed: 6 ms rowSize= 21.840 KBCONCEPT_XREFS gt=2 ms Completed: 2 ms rowSize= 1.152 KBCONCEPT_ANCILLARY gt=0 Completed: 0 ms rowSize= 14 bytes- Reload Stats
|
Genes (13)
Species: human : 13 | |
Human | DLL1 | 28514 | delta-like 1 (Drosophila) | Dlk may regulate the endothelial function in neuroblastic tumors | Human | GALR2 | 8811 | galanin receptor 2 | Elevated expression of galanin receptors in childhood neuroblastic tumors | Human | GALR3 | 8484 | galanin receptor 3 | Elevated expression of galanin receptors in childhood neuroblastic tumors | Human | TP73 | 7161 | tumor protein p73 | data establish a relationship between p73 gene expression and neuroblastic tumor differentiation and point out a role for the p73 gene in sympathetic neuronal differentiation | Human | TP53 | 7157 | tumor protein p53 | Nuclear TP53 accumulation may be relevant in patient's prognosis in neuroblastic tumors | Human | SYP | 6855 | synaptophysin | The presence and distribution of pan-neuroendocrine markers such as neuron-specific enolase (NSE), chromogranin (CG), and synaptophysin (SYP) were investigated by immunohistochemistry in 53 cases of neuroblastic tumors, including three cases of ganglioneuromas, 17 ganglioneuroblastomas, and 33 neuroblastomas. Our observations conclude that antibodies against NSE and SYP are helpful as a diagnostic aid for neuroblastic tumors. | Human | MYCN | 4613 | v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog | With this in view, we analyzed the different hTERT transcripts by reverse transcriptase-polymerase chain reaction in neuroblastic tumors and compared the results with the TA, the tumor growth fraction, and the MYCN status. In neuroblastic tumors, amplification of the MYCN gene is an unequivocal marker that indicates aggressive tumor behavior and is consequently used for therapy stratification. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Childrens Cancer Group. Molecular mechanisms through which MYCN expression contributes to the malignant phenotype of neuroblastoma are unknown.We performed a genome-widegene expression analysis of 40 well-characterized neuroblastic tumors and 12 cell lines to identify genes and biological pathways associated with MYCN expression. In neuroblastic tumors, MYCN amplification was detected in 35.3% of the cases, whereas 1p36 deletion and 17q23 gain was observed in 46.8% and 58.3% of the cases | Human | KIT | 3815 | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | c-kit may have a role in development of neuroblastic tumors | Human | ITGB1 | 3688 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Therefore, we compared the expression of integrin alphaVbeta3, a promiscuous receptor that binds with high affinity to numerous cell matrix proteins, with the expression of integrin alphaVbeta5 and the integrin beta 1 subunit (which pairs with multiple alpha subunits) in neuroblastic tumors at various stages of differentiation. | Human | ITGAV | 3685 | integrin, alpha V | Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells. | Human | GALR1 | 2587 | galanin receptor 1 | Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. In neuroblastic tumors a relationship of differentiation of the tumor to galanin receptor expression and antiproliferative and apoptotic effects upon activation of galanin receptors in neuroblastoma cells was reported. Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. This study provides clear evidence for galanin and galanin receptor expression in human neuroblastic tumours. This study provides clear evidence for galanin and galanin receptor expression in human neuroblastic tumours. We investigated the expression and distribution of galanin and its three known receptors (Gal-R1, Gal-R2, Gal-R3) in 19 samples of neuroblastic tumours tissue by immunohistochemistry, in situ hybridization and fluorescent-ligand binding. | Human | CASP3 | 836 | caspase 3, apoptosis-related cysteine peptidase | We studied 52 neuroblastic tumors to test whether the cell death-related proteases, interleukin-1 beta converting enzyme (ICE), CPP32, and Ich-1, were involved in the regression of the tumors. | Human | CASP2 | 835 | caspase 2, apoptosis-related cysteine peptidase | We studied 52 neuroblastic tumors to test whether the cell death-related proteases, interleukin-1 beta converting enzyme (ICE), CPP32, and Ich-1, were involved in the regression of the tumors. |
|